Citation Impact 2023
Journal Impact Factor: 4.4
5-year Journal Impact Factor: 4.9
Source Normalized Impact per Paper (SNIP): 1.294
SCImago Journal Rank (SJR): 1.518
Speed 2023
Submission to first editorial decision (median days): 9
Submission to acceptance (median days): 111
Usage 2023
Downloads: 3,331,819
Altmetric mentions: 1,885
Articles
Page 131 of 156
-
Citation: Arthritis Res Ther 2003 5(Suppl 3):173
-
Celecoxib: a selective cyclooxygenase-2 inhibitor
Citation: Arthritis Res Ther 2003 5(Suppl 3):172 -
Clinical feature of fibromyalgia syndrome in Japan and novel strategy in the treatment by bioproduct (Neurotropin)
Citation: Arthritis Res Ther 2003 5(Suppl 3):170 -
Exercise: medicine for knee cartilage?
Citation: Arthritis Res Ther 2003 5(Suppl 3):168 -
T cell–chondrocyte interaction in the pathogenesis of osteoarthritis
Citation: Arthritis Res Ther 2003 5(Suppl 3):166 -
Oxidative stress induces chondrocyte telomere instability and chondrocyte dysfunctions in osteoarthritis
Citation: Arthritis Res Ther 2003 5(Suppl 3):164 -
Hepatocyte growth factor in osteoarthritis: when bone and cartilage decide to have a chat
Citation: Arthritis Res Ther 2003 5(Suppl 3):162 -
Humoral, hormonal and genetic determinants of cholinergic dysfunction in Sjögren's syndrome
Citation: Arthritis Res Ther 2003 5(Suppl 3):160 -
Expanded circulating transitional B cells in a patient with systemic lupus erythematosus
Citation: Arthritis Res Ther 2003 5(Suppl 3):158 -
Infliximab for severe ocular inflammation in patients with Behcet's disease
Citation: Arthritis Res Ther 2003 5(Suppl 3):156 -
Pathogenetic roles of Synoviolin in synovial hyperplasia of rheumatoid arthritis
Citation: Arthritis Res Ther 2003 5(Suppl 3):141 -
IL-15 and its role in rheumatoid arthritis
Citation: Arthritis Res Ther 2003 5(Suppl 3):139 -
Galectin-3 and galectin-3 binding protein in rheumatoid arthritis
Citation: Arthritis Res Ther 2003 5(Suppl 3):137 -
The innate immune system as a therapeutic target in arthritis
Citation: Arthritis Res Ther 2003 5(Suppl 3):135 -
Repeated B-cell depletion with rituximab in rheumatoid arthritis
Citation: Arthritis Res Ther 2003 5(Suppl 3):133 -
Therapeutic inhibition of tumour necrosis factor alpha reduces oligoclonality in the selected T-cell receptor BV families in rheumatoid arthritis
Citation: Arthritis Res Ther 2003 5(Suppl 3):131 -
Antirheumatic effects of humanized anti-Fas monoclonal antibody in human rheumatoid arthritis/SCID mouse chimera
Citation: Arthritis Res Ther 2003 5(Suppl 3):129 -
Essential role for migration inhibitory factor in IL-1 activation of mitogen-activated protein kinases
Citation: Arthritis Res Ther 2003 5(Suppl 3):127 -
CD44 regulates bone erosion and osteoclastogenesis in arthritis
Citation: Arthritis Res Ther 2003 5(Suppl 3):125 -
Skewed T-cell receptor BV14 and BV16 expression, and shared complementarity-determining region 3 sequence and common sequence motifs in synovial T cells of rheumatoid arthritis
Citation: Arthritis Res Ther 2003 5(Suppl 3):123 -
Search for the precursor of ectopic follicular dendritic cells
Citation: Arthritis Res Ther 2003 5(Suppl 3):102 -
Antileukoproteinase: modulation of neutrophil function and therapeutic effects in anticollagen II antibody-induced arthritis
Citation: Arthritis Res Ther 2003 5(Suppl 3):100 -
Novel B-lymphocyte-deleting agents for the treatment of autoimmune diseases: induction of the mitochondrial pathway of apoptosis
Citation: Arthritis Res Ther 2003 5(Suppl 3):97 -
The physiological immunosuppressive network and its putative role in the pathogenesis of autoimmunity: inhibition through signaling, cellular contact, anergy, apoptosis
Citation: Arthritis Res Ther 2003 5(Suppl 3):95 -
IL-12 priming during initial antigen contact increases generation of effector and memory CD8 T cells by changing properties
Citation: Arthritis Res Ther 2003 5(Suppl 3):93 -
Role of β1 integrin and its signaling molecule, Cas-L, in pathophysiology and therapeutic interventigens of rheumatoid arthritis
Citation: Arthritis Res Ther 2003 5(Suppl 3):91 -
Post-translational modification of type II collagen influences T-cell tolerance to self-type II collagen
Citation: Arthritis Res Ther 2003 5(Suppl 3):89 -
Transplant-tolerance induction by CTLA-4Ig in liver-transplanted rats: a lesson for the treatment of autoimmune diseases?
Citation: Arthritis Res Ther 2003 5(Suppl 3):87 -
New approach to chemical biology for drug discovery: construction of new affinity beads and their application
Citation: Arthritis Res Ther 2003 5(Suppl 3):85 -
IL-6 as a therapeutic target in systemic-onset juvenile idiopathic arthritis
Citation: Arthritis Res Ther 2003 5(Suppl 3):70 -
IL-1 but not IL-18 induces osteoprotegerin and TRAIL in rheumatoid arthritis synovial fibroblasts
Citation: Arthritis Res Ther 2003 5(Suppl 3):66 -
15-deoxy-delta12,14-prostaglandin J2 induces apoptosis in human articular chondrocytes
Citation: Arthritis Res Ther 2003 5(Suppl 3):64 -
Cartilage-derived morphogenetic protein-1 and cartilage-derived morphogenetic protein-2 are present in ligament fibroblasts and lead to chondrogenic differentiation
Citation: Arthritis Res Ther 2003 5(Suppl 3):62 -
CCAAT/enhancer-binding proteins mediate the repression of transcription of cartilage-derived retinoic acid-sensitive protein induced by IL-1β
Citation: Arthritis Res Ther 2003 5(Suppl 3):60 -
TNF-alpha induced chondrocyte apoptosis in NF-κB suppression is augmented by inhibition of p38 mitogen-activated protein kinase or phosphatidylinositol 3-kinase
Citation: Arthritis Res Ther 2003 5(Suppl 3):58 -
The effect of cyclooxygenase-2 selective inhibitors on the proliferation and apoptosis of human articular chondrocytes
Citation: Arthritis Res Ther 2003 5(Suppl 3):56 -
Role of HC-gp39 in chondrogenesis: upregulation of SOX-9 expression by HC-gp39 in mouse chondrocytes
Citation: Arthritis Res Ther 2003 5(Suppl 3):54 -
Induction of heme oxygenase-1 inhibits IL-1b nitrite oxide production in articular chondrocytes
Citation: Arthritis Res Ther 2003 5(Suppl 3):52 -
TIMP-3 inhibits aggrecan breakdown in pig articular cartilage stimulated with IL-1
Citation: Arthritis Res Ther 2003 5(Suppl 3):48 -
Human adipose tissue is an important novel source of IL-1Ra: a new connection between immuno-inflammatory diseases and lipid metabolism
Citation: Arthritis Res Ther 2003 5(Suppl 3):33 -
Chemokines in rheumatoid arthritis: novel, potential therapeutic targets of the CCR2 chemokine receptor signaling pathway
Citation: Arthritis Res Ther 2003 5(Suppl 3):31 -
A Phase I trial of B-cell depletion with anti-CD20 monoclonal antibody (rituximab) in the treatment of systemic lupus erythematosus
Citation: Arthritis Res Ther 2003 5(Suppl 3):29 -
Analysis of B-cell subpopulations in systemic lupus erythematosus
Citation: Arthritis Res Ther 2003 5(Suppl 3):27 -
Cyclin kinase inhibitors and interferons in lupus
Citation: Arthritis Res Ther 2003 5(Suppl 3):25 -
Role of bone morphogenetic protein signals during skeletal development
Citation: Arthritis Res Ther 2003 5(Suppl 3):23 -
Transcription mechanism of chondrogenesis
Citation: Arthritis Res Ther 2003 5(Suppl 3):21 -
Role of BH3-only protein Bim in autoimmune and degenerative diseases
Citation: Arthritis Res Ther 2003 5(Suppl 3):19 -
Proteomic surveillance of autoimmunity in osteoarthritis
Citation: Arthritis Res Ther 2003 5(Suppl 3):17 -
Toll-like receptor family: receptors essential for microbial recognition and immune responses
Citation: Arthritis Res Ther 2003 5(Suppl 3):15 -
GRAIL: a gene related to anergy in lymphocytes
Citation: Arthritis Res Ther 2003 5(Suppl 3):13